TMCnet News
RaNA Therapeutics to Present at Upcoming ConferencesRaNA Therapeutics, a leader in the discovery and development of a new class of medicines that target RNA, today announced the company's Chief Scientific Officer, Thomas McCauley, Ph.D., will present at the fifth Cold Spring Harbor conference on RNA & Oligonucleotide Therapeutics taking place March 29 - April 1, in Cold Spring Harbor, N.Y. Dr. McCauley's presentation titled, "Taking a multidimensional approach to the discovery & development of RNA therapeutics," will be presented as part of the mRNA therapeutics session on Saturday, April 1. Additionally, Balkrishen Bhat, Ph.D., RaNA's Vice President of Chemistry, will present as chairperson at Cambridge Healthtech Institute's Second Annual Oligonuclotide and Peptide Therapeutics Conference in Cambridge, Mass., on March 28. Dr. Bhat will present an overview of RaNA's mRNA protein up-regulation platforms and will moderate a session about delivery challenges and opportunities in the RNA therapeutics space.
About RaNA Therapeutics View source version on businesswire.com: http://www.businesswire.com/news/home/20170328005464/en/ |